Ep. 60: Strategic planning with Stephen A. Dickens of SVMIC
Stephen A. Dickens, JD, MAEd, FACMPE, vice president of medical practice services at SVMIC talks strategic planning in times of uncertainty.
Related Articles
FDA Approves Larotrectinib for Adult and Pediatric Patients With NTRK Gene Fusion-Positive Solid Tumors
The approval is for those with metastatic disease or in whom surgical resection is likely to result in severe morbidity, have no satisfactory alternative treatments,…
Remote patient monitoring facts, figures and policy recommendations — a slideshow
RPM gets analyzed in a new report by the Peterson Center on Healthcare.
From Inpatient to Outpatient: A Pharmacy-Led Evolution in Transplant Care
Erin Lexner, PharmD, BCPS, discussed her team’s experience transitioning to outpatient BEAM from inpatient CBV.
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria
Multiple phase 3 clinical trials demonstrated dupilumab’s (Dupixent; Regeneron, Sanofi) effectiveness in reducing hives and itch in patients with chronic spontaneous urticaria compared with placebo.
Join the International Forum Utrecht 2025: 21-23 May
The IHI/BMJ International Forum unites the quality improvement community to tackle common challenges. Book now – individual & group packages are available.
Medical education and the physician shortage in the United States
Perspectives from a medical school dean about an alternative path for budding physicians.
FDA Approves Nivolumab With Ipilimumab for First-Line Treatment of Adult Patients With HCC
Patients with unresectable or metastatic hepatocellular carcinoma (HCC) receiving this regimen had favorable median overall survival (23.7 months) compared with standard of care (20.6 months).
Perceptions of consent for a paediatric telehealth trial during emergency transport in Pakistan
Introduction Childhood mortality in the emergency setting is disproportionately high in low-income and middle-income countries (LMIC), with limited research dedicated to improving timely interventions, especially…
Trump takes aim at prescription drug prices as part of health care reforms
Moves prompt praise from opponents of high costs of medications, PBMs.
The Evolving Pharmacist Role in HER2-Negative Adjuvant Breast Cancer Therapy
Julia Ziegengeist, PharmD, BCOP offers insights for pharmacists navigating adjuvant and neoadjuvant treatment of breast cancer.